Narayana Hrudayalaya Ltd. (NSE: NH) is down 5% intraday at ₹1927.3, showing pressure after a recent breakout. This retracement follows resistance clearance.
Park Medi World Limited (PARKHOSPS) announces Q1 FY’27 unaudited results with 19% revenue growth, 20% EBITDA, and 35% net profit surge.
Jupiter Life Line Hospitals Limited (JLHL) stock falls 5% intraday to ₹314.35, breaking below support in a fresh intraday breakdown..
Biocon Limited (BIOCON) announces the U.S. launch of Yesafili™, a biosimilar to Regeneron’s Eylea® 2 mg, expanding access to eye treatment.
Aarti Drugs Limited (NSE: AARTIDRUGS) reports Q1 FY27 revenue up 19% YoY, EBITDA margin expands 120 bps, driven by growth in API & Specialty Chemicals.
SMS Pharmaceuticals Limited (NSE: SMSPHARMA) reports 6% YoY revenue growth in Q1 FY27, driven by high-value APIs and structural improvements.
Zydus Lifesciences Limited (ZYDUSLIFE) receives EIR from USFDA for its injectable facility with Voluntary Action Indicated (VAI) classification.
Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) receives FDA approval for its rituximab biosimilar, expanding its global biosimilars portfolio.
Narayana Hrudayalaya Ltd. (NH) reports a significant surge in revenue and profit for Q1 FY27, showcasing robust financial performance.
Jupiter Life Line Hospitals Limited (JLHL) shares insights from its July 2026 investor presentation, highlighting steady growth and strategic expansion plans.